Antihypertensive Treatment and Multifactorial Approach for Renal Protection in Diabetes-Reference-Cited by-同舟云学术

Antihypertensive Treatment and Multifactorial Approach for Renal Protection in Diabetes

Published:2005-03 Issue:3 suppl 1 Volume:16 Page:S18-S21
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Fioretto Paola,Solini Anna

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference25 articles.

1. Parving H-H, Mauer M, Ritz E: Diabetic nephropathy. In: Brenner and Rector’s the Kidney, 7th Ed., edited by Brenner BM, Philadelphia, WB Saunders, 2004 , pp 1777 –1818

2. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria

3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

4. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy

5. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Resampling Method to Improve the Prognostic Model of End-Stage Kidney Disease: A Better Strategy for Imbalanced Data;Frontiers in Medicine;2022-03-07

2. Possible molecular mechanisms of glucose‐lowering activities of Momordica charantia (karela) in diabetes;Journal of Cellular Biochemistry;2019-02-20

3. Factors associated with diabetic nephropathy in children, adolescents, and adults with type 1 diabetes;Journal of the Formosan Medical Association;2017-12

4. Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial;Clinical Nutrition;2016-08

5. Utilization of angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in patients diagnosed with diabetes: Analysis from the National Ambulatory Medical Care Survey;Preventive Medicine Reports;2016-06